help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Claussen, M.
Right arrow Articles by Braulke, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Claussen, M.
Right arrow Articles by Braulke, T.

Molecular Endocrinology, Vol 9, 902-912, Copyright © 1995 by Endocrine Society

ARTICLES

Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-IL-overexpressing NIH 3T3 cells

M Claussen, D Buergisser, AG Schuller, U Matzner and T Braulke
Institute for Biochemistry II, University of Gottingen, Germany.

Insulin-like growth factor II (IGF-II)-overexpressing NIH 3T3 cells were used to examine regulation of insulin-like growth factor binding protein (IGFBP) and mannose 6-phosphate (M6P)/IGF-II receptor expression. Ligand blot analysis of conditioned media indicated a predominant IGFBP of 26-28 kilodaltons the abundance of which is 3- to 10-fold higher in media of IGF-II-overexpressing cells. The IGFBP level in control cell medium was increased by incubation in the presence of IGF-II, IGF-I, and mutant IGF-II forms with reduced affinities for IGF- I or M6P/IGF-II receptors. Further proof that IGF-II regulated the IGFBP was obtained by incubation of IGF-II overexpressing cells in the presence of antisense IGF-II oligomers or anti-IGF-II antibodies, which resulted in significant reduction of the IGFBP in conditioned medium. Mouse IGFBP-6 mRNA expression was increased in IGF-II-overexpressing or IGF-II-treated control cells. The IGFBP contained O-linked carbohydrate residues and was recognized by an antiserum to rat IGFBP-6. To determine whether IGFs were influencing proteolytic degradation of IGFBPs, cell-free conditioned media were incubated at 37 C with recombinant human IGFBPs. At neutral pH proteolysis of IGFBP-5 occurred during incubation in conditioned media from control and IGF-II- overexpressing cells. Upon acidification of the medium samples, only the degradation of IGFBP-6 was prevented in IGF-II-overexpressing cell- conditioned medium.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
M. Willenborg, C. K. Schmidt, P. Braun, J. Landgrebe, K. von Figura, P. Saftig, and E.-L. Eskelinen
Mannose 6-phosphate receptors, Niemann-Pick C2 protein, and lysosomal cholesterol accumulation
J. Lipid Res., December 1, 2005; 46(12): 2559 - 2569.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. T. Oliver, J. Rosenberger, R. Lopez, A. Gomez, K. K. Cummings, and M. L. Fiorotto
The Local Expression and Abundance of Insulin-Like Growth Factor (IGF) Binding Proteins in Skeletal Muscle Are Regulated by Age and Gender But Not Local IGF-I in Vivo
Endocrinology, December 1, 2005; 146(12): 5455 - 5462.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
T.S. Gadd, J.C. Osgerby, and D.C. Wathes
Regulation of Insulin-Like Growth Factor Binding Protein-6 Expression in the Reproductive Tract Throughout the Estrous Cycle and During the Development of the Placenta in the Ewe
Biol Reprod, December 1, 2002; 67(6): 1756 - 1762.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
E.-L. Eskelinen, A. L. Illert, Y. Tanaka, G. Schwarzmann, J. Blanz, K. von Figura, and P. Saftig
Role of LAMP-2 in Lysosome Biogenesis and Autophagy
Mol. Biol. Cell, September 1, 2002; 13(9): 3355 - 3368.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Shalamanova, B. Kubler, J.-G. Scharf, and T. Braulke
MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1221 - E1229.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. R. SCHNEIDER, H. LAHM, M. WU, A. HOEFLICH, and E. WOLF
Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins
FASEB J, April 1, 2000; 14(5): 629 - 640.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
V. Hwa, Y. Oh, and R. G. Rosenfeld
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily
Endocr. Rev., December 1, 1999; 20(6): 761 - 787.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. A. Marinaro, E. C. Hendrich, K. S. Leeding, and L. A. Bach
HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6
Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E536 - E542.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. Najjar, C. V. Choice, P. Soni, C. M. Whitman, and M. N. Poy
Effect of pp120 on Receptor-mediated Insulin Endocytosis Is Regulated by the Juxtamembrane Domain of the Insulin Receptor
J. Biol. Chem., May 22, 1998; 273(21): 12923 - 12928.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Claussen, B. Kubler, M. Wendland, K. Neifer, B. Schmidt, J. Zapf, and T. Braulke
Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D
Endocrinology, September 1, 1997; 138(9): 3797 - 3803.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society